Company Monitoring Page for Otsuka

job ratings for Otsuka

08/14/22
industry:
pharma
company:
Otsuka
job rating:
1
So disorganized
02/06/21
industry:
Big Pharma
company:
Otsuka
job rating:
1
It’s bizarroworld.
11/15/20
industry:
Big Pharma
company:
Otsuka
job rating:
1
Seriously unqualified execs generating redundant work to look busy for Japan. Leadership looks the other way at middle mgmt’s incompetence. Work done mostly by contractors due to turnover. Miserable employees.
09/07/20
industry:
pharmaceutical sales
job title:
Sales rep - Nephrology
company:
Otsuka
job rating:
1
No pipeline. Highly unorganized. Inept Sr. Management. Poor leadership.
03/28/20
industry:
Big Pharma
job title:
sales rep
company:
Otsuka
job rating:
1
Assholes in management...micromanagment, incompetent execs, nothing new to talk about
01/29/20
industry:
Big Pharma
job title:
salesrep
company:
Otsuka
job rating:
1
Boring as hell, nothing new to talk about, stupid management
01/07/20
industry:
pharma
company:
Otsuka
job rating:
1
Poor leadership
07/28/19
industry:
Big Pharma
job title:
Neuroscience representative
company:
Otsuka
job rating:
1
Nothing new to talk about, no more access to doctors, more sales pressure
03/27/17
industry:
pharmaceutical sales
company:
Otsuka
job rating:
1
Culture; pipeline; upper management

latest headlines for company on cafepharma

Otsuka Drug Candidate Fails Phase III Alzheimer’s Agitation Study
BioSpace
Tue, 02/13/24 - 11:27 am
Tags:
Otsuka, clinical trials, AVP-786, Alzheimer's agitation
FDA rules Otsuka marketing claim overstates Rexulti efficacy, threatening cornerstone of huge TV push
Fierce Pharma
Tue, 11/14/23 - 11:19 am
Tags:
Otsuka, FDA, Rexulti, pharma marketing, clinical depression
Otsuka reports positive data from two Phase III ADHD treatment trials
Clinical Trials Arena
Mon, 10/30/23 - 11:44 am
Tags:
Otsuka, clinical trials, ADHD, centanafadine
Otsuka, Shape Ink Potential $1.5B Deal to Develop Eye AAV Gene Therapies
BioSpace
Fri, 09/8/23 - 10:11 am
Tags:
Otsuka, Shape Therapeutics, gene therapy, AAV gene therapy, RNA editing, ocular diseases
Evaluating renal denervation rivals, FDA advisory panel backs ReCor, shuns Medtronic
Fierce Biotech
Fri, 08/25/23 - 09:51 am
Tags:
Medtech, FDA, renal denervation, Otsuka, Recor, Medtronic, hypertension
Sumitomo, Otsuka’s Schizophrenia Candidate Fails Phase III Trials
BioSpace
Mon, 07/31/23 - 09:50 pm
Tags:
Sumitomo Pharma, Otsuka, clinical trials, ulotaront, schizophrenia
Hope springs for April inhibition
EP Vantage
Tue, 06/13/23 - 10:27 am
Tags:
Novartis, Chinook Therapeutics, April inhibition, M&A, Vera Therapeutics, Otsuka, RemeGen, Alpine Immune Sciences, Akso Biopharmaceutical, Aurinia Pharmaceuticals
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Yahoo/Benzinga
Thu, 05/11/23 - 08:53 pm
Tags:
Otsuka, Lundbeck, FDA, Rexulti, Alzheimer's agitation
Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify
Fierce Pharma
Mon, 05/1/23 - 10:04 am
Tags:
Otsuka, Lundbeck, FDA, Abilify, Asimtufii, bipolar disorder
Sunovion, Otsuka randomize first patient for GAD Phase II/III study
Clinical Trials Arena
Thu, 04/27/23 - 10:27 am
Tags:
Sunovion, Otsuka, clinicat trials, ulotaront, generalized anxiety disorder
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation
Fierce Pharma
Sun, 04/16/23 - 11:17 pm
Tags:
Lundbeck, Otsuka, Rexulti, Alzheimer's disease, FDA
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
Tags:
FDA, AbbVie, Alvotech, Ascendis Pharma, Astellas, AstraZeneca, Biogen, Daiichi Sankyo, Eli Lilly, Ferring Pharmaceuticals, Hugel, Innoviva, Ionis Pharmaceuticals, Lundbeck, Merck, Novo Nordisk, Otsuka, Pfizer, Roche Seagen, Seres Therapeutics, Takeda, UCB, Vertex Pharmaceuticals
Otsuka, Lundbeck eye Alzheimer's indication in FDA adcomm for Rexulti label expansion
Endpoints
Thu, 03/30/23 - 10:02 am
Tags:
Otsuka, Lundbeck, Alzheimer's disease, FDA, Rexulti, Alzheimer's disease agitation
Despite recent approvals, significant unmet need remains in Alzheimer’s market
Clinical Trials Arena
Wed, 03/1/23 - 10:05 am
Tags:
Alzheimer's disease, Biogen, Eisai, Lundbeck, Otsuka, Avanir Pharmaceuticals, Axesome, Aduhelm, Leqembi
Alphabet's Verily to trial antidepressants
Beckers Hospital Review
Thu, 02/2/23 - 10:42 am
Tags:
Alphabet, Verily, Otsuka, antidepressants, centanafadine, clinical trials
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
Tags:
television ads, pharma marketing, DTC ads, AbbVie, Rinvoq, Dupixent, Sanofi, Regeneron, Skyrizi, Novo Nordisk, Ozempic, Jardiance, Eli Lilly, Boehringer Ingelheim, Rybelsus, Trulicity, Rexulti, Otsuka, Lundbeck, Tremfya, JNJ, Verzenio
FDA greenlights Otsuka subsidiary's bile duct cancer drug
Endpoints
Mon, 10/3/22 - 10:04 am
Tags:
Otsuka, Taiho Oncology, Lytgobi, bile duct cancer, FDA
TCT 2022 – Otsuka’s renal denervation system shines
EP Vantage
Thu, 09/22/22 - 10:08 am
Tags:
Otsuka, Recor, devices, Medtech, TCT, renal denervation, Paradise
FDA accepts Otsuka, Lundbeck filing for long-acting schizophrenia drug, teeing up April decision date
Fierce Pharma
Tue, 09/13/22 - 10:50 am
Tags:
Otsuka, Lundbeck, schizophrenia, FDA, bipolar disorder, Abilify Maintena
Akebia Regains Rights to Anemia Drug After Otsuka Partnership Dissolves
BioSpace
Mon, 07/4/22 - 11:56 pm
Tags:
Otsuka, Akebia, vadadustat, anemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.